Search
for
Sort by
Research 301–330 of 526
- Hormonal Effects on Hair Follicles
- Minoxidil: a review of its pharmacological properties and therapeutic use.
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Recent Advances in the Controlled Release of Growth Factors and Cytokines for Improving Cutaneous Wound Healing
- Hox genes in development and beyond
- Vitiligo - Part 2 - classification, histopathology and treatment
- Amino acid–derived defense metabolites from plants: A potential source to facilitate novel antimicrobial development
- Micropatterned dermal–epidermal regeneration matrices create functional niches that enhance epidermal morphogenesis
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
- “Sebocytes’ makeup” - Novel mechanisms and concepts in the physiology of the human sebaceous glands
- Epidermal Nevi
- Bi-allelic Mutations in LSS, Encoding Lanosterol Synthase, Cause Autosomal-Recessive Hypotrichosis Simplex
- A review for cell-based screening methods in drug discovery
- Finasteride use in the male infertility population: effects on semen and hormone parameters
- Immune Privilege Collapse and Alopecia Development: Is Stress a Factor
- Morphea: progress to date and the road ahead
- An overview of the genetic aspects of hair loss and its connection with nutrition
- Topical drug delivery strategies for enhancing drug effectiveness by skin barriers, drug delivery systems and individualized dosing
- Nanobiotechnology: Applications in Chronic Wound Healing
- Alopecia With Endocrine Therapies in Patients With Cancer
- Hormonal Therapies for Individuals with Intersex Conditions
- Dermatologic care for lesbian, gay, bisexual, and transgender persons
- Distinct mechanisms for sebaceous gland self-renewal and regeneration provide durability in response to injury
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- The potential application of natural products in cutaneous wound healing: A review of preclinical evidence
- Gelatin-chondroitin-6-sulfate-hyaluronic acid scaffold seeded with vascular endothelial growth factor 165 modified hair follicle stem cells as a three-dimensional skin substitute
- Functional Skin Grafts: Where Biomaterials Meet Stem Cells
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods